Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 7/2019

01-10-2019 | CE - MEDICAL ILLUSTRATION

Large paraganglioma at the organ of Zuckerkandl

Published in: Internal and Emergency Medicine | Issue 7/2019

Login to get access

Excerpt

A 34-year-old female with no prior medical history presented to gynaecology with lower abdominal pain and abnormal uterine bleeding. A suprapubic mass, believed to be a multifibroid uterus, was palpable on abdominal examination. …
Literature
1.
Ilias I, Pacak K (2008) A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors. Nucl Med Biol 35:S1:27–S1:38CrossRef
2.
Lenders JWM et al (2014) Pheochromocytoma and paraganglioma: an Endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915–1942CrossRefPubMed
3.
Costa MHS, Ortiga-Carvalho TM, Violante AD, Vaisman M (2015) Pheochromocytomas and paragangliomas: clinical and genetic approaches. Front Endocrinol 6:1–9CrossRef
Metadata
Title
Large paraganglioma at the organ of Zuckerkandl
Publication date
01-10-2019
Published in
Internal and Emergency Medicine / Issue 7/2019
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02133-0

Other articles of this Issue 7/2019

Internal and Emergency Medicine 7/2019 Go to the issue

IM - Commentary

Atrial fibrillation and kidney disease: insights on a close relationship

IM - COMMENTARY

Risk stratification in hospitalized heart failure patients: do the RIGHT thing!

IM - ORIGINAL

Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction

THE CUTTING EDGE: RESEARCH UPDATE

Assessment of epinephrine efficacy in out-of-hospital cardiac arrest

Correction

Correction to: Intranasal sufentanil given in the emergency department triage zone for severe acute traumatic pain—a randomized double‑blind controlled trail: comment

IM - ORIGINAL

Comparison of incidence of acute kidney injury, chronic kidney disease and end-stage renal disease between atrial fibrillation and atrial flutter: real-world evidences from a propensity score-matched national cohort analysis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits